Cathy Garabedian

Cathy is currently Senior Director of New Product Planning (NPP) at Keros Therapetuics. She previously held positions in business development, NPP, and marketing at companies including Alkermes, Sage Therapeutics, and X4 Pharmaceuticals. Cathy is passionate about leveraging market research, KOL and patient engagement, and commercial analytics and intelligence to drive strategic decisions about early product profiles, positioning and corporate planning. Cathy holds a Bachelor of Science from Brown University and a PhD in Neuroscience from the University of California, San Francisco. In her spare time she enjoys walking on Nantasket beach, reading, and marveling at her vegetable garden